Patient Access in Non-Traditional Regions

For faster trials, start farther from home

Almost 80% of all clinical trials run behind schedule, and patient recruitment is the leading cause of delay. In fact, recruitment delays account for up to 95% of all days lost. To keep trials on schedule - or even ahead of schedule – Quintiles is increasingly leveraging its global reach.

More and more customers are discovering the advantages of conducting trials in the diverse non-traditional regions of the world, where patient populations, well-trained investigators and high-quality communications systems are readily available – and where Quintiles has had experience mastering local disease profiles, customs and regulations. By putting it all together, we deliver speedy study startup and top quality results that meet FDA and ICH GCP standards.

Expanded reach, easier access to specific patient populations

Different therapeutic indications tend to cluster in different regions of the world. Quintiles staff in non-traditional regions includes physician specialists in key therapeutic areas to help fine tune study design and protocols. Patients in non-traditional regions have a high rate of protocol compliance and low dropout rates, because of the high standards of medical care available through clinical trials. This and our combination of global reach and local knowledge can result in speedy recruitment of specific patient populations.